Navigation Links
Biomarkers May Predict Aggressiveness of Prostate Cancer
Date:5/5/2009

n markers taken at diagnosis and long-term mortality had not been shown before," he said. "Perhaps the editorial is concerned about inappropriate, excessive use of these markers -- and, if so, we would agree."

More information

The U.S. National Cancer Institute has more on prostate cancer.



SOURCES: John Concato, M.D., professor, medicine, Yale University, and director, Clinical Epidemiological Research Center, Veterans Affairs Connecticut Healthcare System, New Haven, Conn.; Edward P. Gelmann, M.D., chief, division of hematology/oncology, and deputy director, Herbert Irving Comprehensive Cancer Center, Columbia University, New York City; May 5, 2009, Annals of Internal Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Vitamin D Linked to HDL Cholesterol - Shaklee Corporation Research Links Vitamin D with Key Biomarkers for Metabolic Syndrome and Heart Disease
2. Potential lung disease biomarkers yield clues to COX-2 inhibitor side effects
3. Cordex Pharma to Collaborate with BG Medicine in a Clinical Study of Heart Failure Biomarkers
4. Biomarkers detected for Chikungunya fever
5. Frost & Sullivan Lauds Toscana Biomarkers Outstanding Contributions to the R&D of Novel Biomarkers for the Diagnosis of Autoimmune Diseases
6. Thomson Reuters White Paper Explores the Role of Biomarkers in Clinical Trials and Drug Development
7. Biomarkers improve ischemic stroke prediction
8. Biomarkers: What can they tell us
9. PreMD Files Provisional Patent Application Describing a New Method of Quantifying Cancer Biomarkers
10. Biomarkers May Help Spot, Track Alzheimers
11. Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Biomarkers May Predict Aggressiveness of Prostate Cancer
(Date:10/22/2014)... On October 22, CBS will air an ... both fictional and real. The Charles E Holman ... to advocacy and philanthropy in the battle against Morgellons ... to impart truth and clarity about this misunderstood and ... misconceptions about Morgellons Disease (MD) and most ...
(Date:10/22/2014)... 22, 2014 For Dr. Iris Hunter, a ... it’s an extension of her life’s mission. Her extensive experience ... the owner of FirstLight HomeCare, make it clear that Hunter’s ... me that my work makes a difference in the lives ... spirit, so after much research, I felt ready to start ...
(Date:10/22/2014)... 22, 2014 Shriners Hospitals for Children® ... change the current location of Shriners Hospitals for Children ... across from the University of Kentucky Albert B. Chandler ... care center, owned and operated by Shriners Hospitals for ... of children and their families well into the future. ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 With the Affordable ... national survey by the American Institutes for Research (AIR) finds ... how to use health insurance, but 42 percent say they ... plan’s details before signing up for coverage. , The AIR ... only 20 percent able to calculate correctly how much they ...
(Date:10/22/2014)... Healthcare professionals who are looking ... at home or on-the-go via laptops, tablets or ... new, premium Seminar-on-Demand CE courses. The new courses ... 2,000 hours of CE course offerings, allowing ... With such a diverse library, there’s something for ...
Breaking Medicine News(10 mins):Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Dr. Iris Hunter to Host Grand Opening of FirstLight HomeCare Tomorrow 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2
... tests, but side effects concern researchers , FRIDAY, Jan. ... longer prescribed may find new life as an effective ... as clorgyline, hasn,t been tested in humans as a ... can reduce and even reverse the symptoms of heart ...
... in those who worked out while dieting , THURSDAY, Jan. ... this year, consider adding a regular exercise program while you,re ... outcomes -- such as lower blood pressure and cholesterol levels ... , "It,s better to lose weight with a combination of ...
... sleep nightly, study finds, , FRIDAY, Jan. 8 (HealthDay News) ... teachers of adolescents, a new study finds that most U.S. ... the study found that almost 69 percent of high school ... about 8 percent of teens get the optimal amount -- ...
... messaging from quitline specialists (i.e., stressing the benefits ... those who received standard-care messaging (i.e., potential losses ... a new study published online January 7 in ... . Researchers also established that quitline specialists can ...
... to genetically modify human embryonic stem cells. Their approach, which ... genes, will make possible the rapid development of stem cell ... diseases and as testbeds on which to screen potential treatments, ... whole human embryonic stem cell field. Otherwise, there,s really few ...
... has shown that metformin, a drug often used in the ... patients who have both diabetes and advanced heart failure. The ... by researchers at the David Geffen School of Medicine ... "There may be over two million individuals with heart failure ...
Cached Medicine News:Health News:Older Antidepressant May Treat Heart Failure 2Health News:For Fitness, Cutting Calories May Not Be Enough 2Health News:For Fitness, Cutting Calories May Not Be Enough 3Health News:Two-Thirds of American Teens Need More Shut-Eye 2Health News:Two-Thirds of American Teens Need More Shut-Eye 3Health News:Quitline messages that stress benefits of quitting may improve smoking cessation 2Health News:Biologists develop efficient genetic modification of human embryonic stem cells 2Health News:Biologists develop efficient genetic modification of human embryonic stem cells 3Health News:UCLA study shows metformin is safe for patients with advanced heart failure and diabetes mellitus 2
(Date:10/22/2014)... LA JOLLA, Calif. , Oct. 22, ... RGLS ), a biopharmaceutical company leading ... targeting microRNAs, today announced that it has ... from an ongoing clinical study evaluating RG-101, ... for the treatment of hepatitis C virus ...
(Date:10/20/2014)... , Oct. 20, 2014  Indianapolis interventional ... Toronto -based 3D visualization leader ... Congress of Neurological Surgeons Annual Meeting that they ... for brain surgery. The collaboration is the first ... combination to improve patient outcomes. NICO,s BrainPath® interventional ...
(Date:10/20/2014)... 20, 2014   BioNano Genomics announced today achievement ... to collect human data at 30X depth, sufficient for a ... new capability was established and demonstrated for the IrysChip TM ... System and will be rolled out to BioNano,s ... be showcasing this advancement at the American Society for ...
Breaking Medicine Technology:A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5BioNano Genomics Announces One Human : One Chip : One Day 2BioNano Genomics Announces One Human : One Chip : One Day 3
... Site Solutions Summit, an annual conference of premier clinical ... their 2010 Site Solutions Summit Eagle Awards to Eli ... PPD, Inc., as the top contract research organization (CRO). ... CRO for their commitment to outstanding leadership, professionalism, integrity, ...
... Cardiogenesis Corporation (OTCQB: CGCP) announced that the company will ... 2010 on Wednesday, November 3, 2010.  The company added ... R. Abbott, its Senior Vice President and Chief Financial ... at 5:00 p.m. Eastern time (2:00 p.m. Pacific time) ...
Cached Medicine Technology:Eli Lilly and Company and PPD, Inc., Honored for Building Strong Clinical Research Site Partnerships at the Site Solutions Summit Annual Meeting 2Eli Lilly and Company and PPD, Inc., Honored for Building Strong Clinical Research Site Partnerships at the Site Solutions Summit Annual Meeting 3Eli Lilly and Company and PPD, Inc., Honored for Building Strong Clinical Research Site Partnerships at the Site Solutions Summit Annual Meeting 4Cardiogenesis Corporation to Report 2010 Third Quarter Results on November 3rd 2
... helps protect you against needlestick injury. Its ... exposure to a contaminated needle, provides easy ... for use in high-risk environments. The one-handed ... for activation of the safety mechanism while ...
... The Omni-Flex System provides the ... in the middle of surgery ... on the incision. The system ... be stable for large patients ...
... The genuine BOOKWALTER™ Retractor System ... fixed" retractor design available. Its wide ... surgical specialites with a versatile system ... field. Individual BOOKWALTER™ Kits are available ...
... the Alexis Wound Retractor provides circumferential ... contamination. For open surgery, the Alexis ... the incision size. For laparoscopic surgery, ... offering retraction and protection when an ...
Medicine Products: